Artisan Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5B Buy
5,127,175
+94,424
+2% +$31M 2.45% 5
2025
Q4
$1.76B Buy
5,032,751
+455,946
+10% +$154M 2.7% 3
2025
Q3
$1.48B Buy
4,576,805
+901,626
+25% +$280M 2.13% 8
2025
Q2
$1.43B Buy
3,675,179
+324,399
+10% +$130M 2.13% 7
2025
Q1
$1.46B Buy
3,350,780
+474,930
+17% +$191M 2.36% 3
2024
Q4
$1.06B Buy
2,875,850
+437,103
+18% +$183M 1.63% 13
2024
Q3
$1.27B Buy
2,438,747
+77,819
+3% +$41.6M 1.9% 6
2024
Q2
$1.28B Sell
2,360,928
-11,341
-0.5% -$5.99M 1.95% 6
2024
Q1
$1.23B Buy
2,372,269
+59,616
+3% +$29.6M 1.79% 7
2023
Q4
$1.09B Sell
2,312,653
-66,393
-3% -$30.7M 1.71% 12
2023
Q3
$1.04B Buy
2,379,046
+160,524
+7% +$72.8M 1.76% 10
2023
Q2
$986M Sell
2,218,522
-140,119
-6% -$64.6M 1.59% 13
2023
Q1
$1.08B Sell
2,358,641
-48,502
-2% -$23.1M 1.8% 10
2022
Q4
$1.23B Sell
2,407,143
-207,510
-8% -$105M 2.19% 4
2022
Q3
$1.19B Buy
2,614,653
+87,601
+3% +$41.9M 2.1% 7
2022
Q2
$1.22B Sell
2,527,052
-815,657
-24% -$404M 2.07% 4
2022
Q1
$1.64B Sell
3,342,709
-32,584
-1% -$14.9M 2.18% 4
2021
Q4
$1.56B Sell
3,375,293
-10,804
-0.3% -$4.55M 1.87% 5
2021
Q3
$1.26B Buy
3,386,097
+130,565
+4% +$49.6M 1.55% 7
2021
Q2
$1.24B Sell
3,255,532
-107,155
-3% -$40.9M 1.49% 7
2021
Q1
$1.21B Buy
3,362,687
+956,173
+40% +$307M 1.57% 4
2020
Q4
$773M Buy
2,406,514
+259,562
+12% +$79.7M 0.97% 29
2020
Q3
$577M Buy
2,146,952
+483,845
+29% +$130M 0.83% 36
2020
Q2
$437M Buy
1,663,107
+306,601
+23% +$81.8M 0.71% 49
2020
Q1
$308M Sell
1,356,506
-880,647
-39% -$240M 0.66% 51
2019
Q4
$676M Buy
2,237,153
+902,478
+68% +$248M 1.19% 26
2019
Q3
$320M Sell
1,334,675
-273,890
-17% -$75M 0.61% 52
2019
Q2
$454M Sell
1,608,565
-19,111
-1% -$5.22M 0.84% 40
2019
Q1
$467M Sell
1,627,676
-263,261
-14% -$76.1M 0.92% 38
2018
Q4
$497M Sell
1,890,937
-45,012
-2% -$12.4M 1.12% 26
2018
Q3
$531M Buy
1,935,949
+147,561
+8% +$38.3M 1.01% 28
2018
Q2
$426M Buy
1,788,388
+512,962
+40% +$119M 0.85% 34
2018
Q1
$280M Buy
1,275,426
+275,393
+28% +$64.7M 0.57% 50
2017
Q4
$225M Sell
1,000,033
-382,174
-28% -$81.4M 0.43% 76
2017
Q3
$262M Sell
1,382,207
-198,162
-13% -$37.7M 0.49% 59
2017
Q2
$297M Buy
1,580,369
+84,695
+6% +$15.2M 0.56% 44
2017
Q1
$247M Buy
1,495,674
+49,600
+3% +$7.89M 0.48% 58
2016
Q4
$208M Buy
1,446,074
+238,476
+20% +$31.9M 0.43% 70
2016
Q3
$151M Buy
1,207,598
+140,749
+13% +$18.2M 0.3% 100
2016
Q2
$140M Buy
1,066,849
+330,145
+45% +$45.2M 0.3% 100
2016
Q1
$102M Buy
736,704
+219,769
+43% +$29.4M 0.21% 130
2015
Q4
$72.1M Buy
516,935
+40,217
+8% +$5.54M 0.14% 156
2015
Q3
$66.7M Buy
+476,718
New +$71.6M 0.14% 159

Other funds holding ELV